These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 34880218

  • 1. Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice.
    Kenjo E, Hozumi H, Makita Y, Iwabuchi KA, Fujimoto N, Matsumoto S, Kimura M, Amano Y, Ifuku M, Naoe Y, Inukai N, Hotta A.
    Nat Commun; 2021 Dec 08; 12(1):7101. PubMed ID: 34880218
    [Abstract] [Full Text] [Related]

  • 2. Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy.
    Bengtsson NE, Hall JK, Odom GL, Phelps MP, Andrus CR, Hawkins RD, Hauschka SD, Chamberlain JR, Chamberlain JS.
    Nat Commun; 2017 Feb 14; 8():14454. PubMed ID: 28195574
    [Abstract] [Full Text] [Related]

  • 3. Creation of a Novel Humanized Dystrophic Mouse Model of Duchenne Muscular Dystrophy and Application of a CRISPR/Cas9 Gene Editing Therapy.
    Young CS, Mokhonova E, Quinonez M, Pyle AD, Spencer MJ.
    J Neuromuscul Dis; 2017 Feb 14; 4(2):139-145. PubMed ID: 28505980
    [Abstract] [Full Text] [Related]

  • 4. Full-length dystrophin restoration via targeted exon integration by AAV-CRISPR in a humanized mouse model of Duchenne muscular dystrophy.
    Pickar-Oliver A, Gough V, Bohning JD, Liu S, Robinson-Hamm JN, Daniels H, Majoros WH, Devlin G, Asokan A, Gersbach CA.
    Mol Ther; 2021 Nov 03; 29(11):3243-3257. PubMed ID: 34509668
    [Abstract] [Full Text] [Related]

  • 5. Molecular correction of Duchenne muscular dystrophy by splice modulation and gene editing.
    Hanson B, Wood MJA, Roberts TC.
    RNA Biol; 2021 Jul 03; 18(7):1048-1062. PubMed ID: 33472516
    [Abstract] [Full Text] [Related]

  • 6. Correction of Three Prominent Mutations in Mouse and Human Models of Duchenne Muscular Dystrophy by Single-Cut Genome Editing.
    Min YL, Chemello F, Li H, Rodriguez-Caycedo C, Sanchez-Ortiz E, Mireault AA, McAnally JR, Shelton JM, Zhang Y, Bassel-Duby R, Olson EN.
    Mol Ther; 2020 Sep 02; 28(9):2044-2055. PubMed ID: 32892813
    [Abstract] [Full Text] [Related]

  • 7. CRISPR-Cas9 Correction of Duchenne Muscular Dystrophy in Mice by a Self-Complementary AAV Delivery System.
    Zhang Y, Bassel-Duby R, Olson EN.
    Methods Mol Biol; 2023 Sep 02; 2587():411-425. PubMed ID: 36401041
    [Abstract] [Full Text] [Related]

  • 8. Gene editing of Duchenne muscular dystrophy using biomineralization-based spCas9 variant nanoparticles.
    Li S, Du M, Deng J, Deng G, Li J, Song Z, Han H.
    Acta Biomater; 2022 Dec 02; 154():597-607. PubMed ID: 36243370
    [Abstract] [Full Text] [Related]

  • 9. Enhanced CRISPR-Cas9 correction of Duchenne muscular dystrophy in mice by a self-complementary AAV delivery system.
    Zhang Y, Li H, Min YL, Sanchez-Ortiz E, Huang J, Mireault AA, Shelton JM, Kim J, Mammen PPA, Bassel-Duby R, Olson EN.
    Sci Adv; 2020 Feb 02; 6(8):eaay6812. PubMed ID: 32128412
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy.
    Nelson CE, Hakim CH, Ousterout DG, Thakore PI, Moreb EA, Castellanos Rivera RM, Madhavan S, Pan X, Ran FA, Yan WX, Asokan A, Zhang F, Duan D, Gersbach CA.
    Science; 2016 Jan 22; 351(6271):403-7. PubMed ID: 26721684
    [Abstract] [Full Text] [Related]

  • 12. Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy.
    Moretti A, Fonteyne L, Giesert F, Hoppmann P, Meier AB, Bozoglu T, Baehr A, Schneider CM, Sinnecker D, Klett K, Fröhlich T, Rahman FA, Haufe T, Sun S, Jurisch V, Kessler B, Hinkel R, Dirschinger R, Martens E, Jilek C, Graf A, Krebs S, Santamaria G, Kurome M, Zakhartchenko V, Campbell B, Voelse K, Wolf A, Ziegler T, Reichert S, Lee S, Flenkenthaler F, Dorn T, Jeremias I, Blum H, Dendorfer A, Schnieke A, Krause S, Walter MC, Klymiuk N, Laugwitz KL, Wolf E, Wurst W, Kupatt C.
    Nat Med; 2020 Feb 22; 26(2):207-214. PubMed ID: 31988462
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Dystrophin Gene-Editing Stability Is Dependent on Dystrophin Levels in Skeletal but Not Cardiac Muscles.
    Bengtsson NE, Tasfaout H, Hauschka SD, Chamberlain JS.
    Mol Ther; 2021 Mar 03; 29(3):1070-1085. PubMed ID: 33160075
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Guanidinium-Rich Lipopeptide-Based Nanoparticle Enables Efficient Gene Editing in Skeletal Muscles.
    Zhu M, Wang X, Xie R, Wang Y, Xu X, Burger J, Gong S.
    ACS Appl Mater Interfaces; 2023 Mar 01; 15(8):10464-10476. PubMed ID: 36800641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.